826
Views
16
CrossRef citations to date
0
Altmetric
Review

Posaconazole in immunocompromised pediatric patients

&
Pages 543-553 | Received 19 Feb 2018, Accepted 14 Jun 2018, Published online: 03 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qin Ding, Shuqi Huang, Zexu Sun, Kaifeng Chen, Xin Li & Qi Pei. (2022) A Review of Population Pharmacokinetic Models of Posaconazole. Drug Design, Development and Therapy 16, pages 3691-3709.
Read now
Paraskevi Panagopoulou & Emmanuel Roilides. (2022) Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections. Expert Opinion on Pharmacotherapy 23:2, pages 175-199.
Read now

Articles from other publishers (14)

Sarah Allegra, Francesco Chiara & Silvia De Francia. (2022) Posaconazole plasma concentrations in children and adolescent. Pharmacy & Pharmacology International Journal 10:6, pages 196-199.
Crossref
Mengmeng Jia, Qiwen Zhang, Zifei Qin, Dao Wang, Peng Liu, Jing Yang & Xiaojian Zhang. (2022) Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients. Frontiers in Pharmacology 13.
Crossref
Benjamin KablyManon LaunayAudrey DerobertmasureSandrine Lefeuvre, Eric DannaouiEliane M. Billaud. (2022) Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring 44:1, pages 166-197.
Crossref
Julio Maquera-Afaray, Medalit Luna-Vilchez, Blanca Salazar-Mesones, Diana Portillo-Alvarez, Luis Uribe-Ramirez, Graciela Taipe-Sedano, Carlos Santillán-Salas & José W. López. (2022) Antifungal Prophylaxis With Posaconazole in Immunocompromised Children Younger Than 13 Years. The Journal of Pediatric Pharmacology and Therapeutics 27:1, pages 57-62.
Crossref
Tuğçe Tural Kara, Ergin Çiftçi & Emin Sami Arısoy. 2022. Pediatric ENT Infections. Pediatric ENT Infections 1031 1041 .
Antonio C. Arrieta, Michael Neely, J. Christopher Day, Susan R. Rheingold, Paul K. Sue, William J. Muller, Lara A. Danziger-Isakov, Julie Chu, Inci Yildirim, Grace A. McComsey, Haydar A. Frangoul, Tempe K. Chen, Victoria A. Statler, William J. Steinbach, Dwight E. Yin, Kamal Hamed, Mark E. Jones, Christopher Lademacher, Amit Desai, Kelley Micklus, Desiree Leiva Phillips, Laura L. Kovanda & Thomas J. Walsh. (2021) Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients. Antimicrobial Agents and Chemotherapy 65:8.
Crossref
Yan Liang, Xing Chen, Jinrong Wang, Chunyan Guo, Fengqin Liu & Juan Yang. (2021) Oral posaconazole and bronchoscopy as a treatment for pulmonary mucormycosis in pediatric acute lymphoblastic leukemia patient. Medicine 100:6, pages e24630.
Crossref
Charalampos Antachopoulos & Emmanuel Roilides. (2020) Pharmacokinetics and Pharmacodynamics of Antifungal Agents in Neonates and Children. Current Fungal Infection Reports 14:3, pages 317-328.
Crossref
Margherita Mauro, Antonella Colombini, Katia Perruccio, Daniele Zama, Maria Rosaria D'Amico, Elisabetta Calore, Francesca Carraro, Paola Muggeo, Gloria Tridello, Valentina Baretta & Simone Cesaro. (2020) Posaconazole delayed‐release tablets in paediatric haematology–oncology patients. Mycoses 63:6, pages 604-609.
Crossref
Lu Chen, Elke H. J. Krekels, Paul. E. Verweij, Jochem B. Buil, Catherijne A. J. Knibbe & Roger J. M. Brüggemann. (2020) Pharmacokinetics and Pharmacodynamics of Posaconazole. Drugs 80:7, pages 671-695.
Crossref
Tony Lai, Jan-Willem Alffenaar, Alison Kesson, Sushil Bandodkar & Jason A Roberts. (2020) Evaluation of target attainment of oral posaconazole suspension in immunocompromised children. Journal of Antimicrobial Chemotherapy 75:3, pages 726-729.
Crossref
Deepa Patel, Sarah Popple, Alison Claydon, Deborah E Modha & Erol A Gaillard. (2020) Posaconazole therapy in children with cystic fibrosis and Aspergillus-related lung disease. Medical Mycology 58:1, pages 11-21.
Crossref
Athanasios Tragiannidis, Heidrun Herbrüggen, Martina Ahlmann, Eleni Vasileiou, Silke Gastine, Heike Thorer, Birgit Fröhlich, Carsten Müller & Andreas H Groll. (2019) Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents. Journal of Antimicrobial Chemotherapy 74:12, pages 3573-3578.
Crossref
James B. Wood, Lauryn B. Cravens & C. Buddy Creech. (2019) Advances in pediatric antimicrobial agents development. Current Opinion in Pediatrics 31:1, pages 135-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.